Skip to contentKrishnan Suma — Krystal Biotech, Inc. insider: 355 transactions · InsiderLensKrishnan Suma
- Vice President, Product Dev. at NEW RIVER PHARMACEUTICALS INC · on record since Mar 22, 2006
- Director at NEW RIVER PHARMACEUTICALS INC · on record since May 19, 2006
- SVP--Product Development at PRECIGEN, INC. · on record since Mar 24, 2014
- Director at Krystal Biotech, Inc. · on record since Jun 5, 2026
- 10% owner at Krystal Biotech, Inc. · on record since Jun 5, 2026
- President, R&D at Krystal Biotech, Inc. · on record since Sep 25, 2017
Insider trading activity of Krishnan Suma
- Transactions on record
- 355
- since Aug 11, 2004
- Open-market buys
- 8
- $2.1M
- Open-market sells
- 238
- $136.3M
- Companies traded
- 3
- last filing Jun 5, 2026
Figures computed from official regulatory filings — methodology.
Companies where Krishnan Suma has traded
Track record of Krishnan Suma
Statistical track record
Free- Open-market buys
- 8
- Last buy
- Oct 18, 2018
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Krishnan Suma
Co-insiders of Krishnan Suma
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Bobo Jack APRECIGEN, INC.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 5, 2026 | Sell | -240 | 311.65 USD | $74.8K | SEC |
| Jun 5, 2026 | Sell | -400 | 304.89 USD | $122K | SEC |
| Jun 5, 2026 | Sell | -480 | 305.87 USD | $146.8K | SEC |
| Jun 5, 2026 | Sell | -247 | 303.17 USD | $74.9K | SEC |
| Jun 5, 2026 | Sell | -2,039 | 310.94 USD | $634K | SEC |
| Jun 5, 2026 | Sell | -320 | 300.75 USD | $96.2K | SEC |
| Jun 5, 2026 | Sell | -1,348 | 307.09 USD | $414K | SEC |
| Jun 5, 2026 | Sell | -2,801 | 309.95 USD | $868.2K | SEC |
| Jun 5, 2026 | Sell | -3,803 | 308.89 USD | $1.2M | SEC |
| Jun 5, 2026 | Sell | -593 | 302.25 USD | $179.2K | SEC |
| Jun 5, 2026 | Sell | -12,729 | 307.81 USD | $3.9M | SEC |
| Mar 6, 2026 | Sell | -2,931 | 261.41 USD | $766.2K | SEC |
| Mar 6, 2026 | Sell | -3,667 | 260.37 USD | $954.8K | SEC |
| Mar 6, 2026 | Sell | -407 | 257.32 USD | $104.7K | SEC |
| Mar 6, 2026 | Sell | -589 | 258.54 USD | $152.3K | SEC |
| Mar 6, 2026 | Sell | -1,938 | 262.35 USD | $508.4K | SEC |
| Mar 6, 2026 | Sell | -668 | 259.61 USD | $173.4K | SEC |
| Mar 6, 2026 | Sell | -6,000 | 265.16 USD | $1.6M | SEC |
| Mar 6, 2026 | Sell | -2,248 | 263.58 USD | $592.5K | SEC |
| Mar 6, 2026 | Sell | -1,700 | 266.42 USD | $452.9K | SEC |
| Mar 6, 2026 | Sell | -4,852 | 264.64 USD | $1.3M | SEC |
| Mar 3, 2026 | Exercise | 5,725 | 0.00 USD | $0 | SEC |
| Mar 3, 2026 | Exercise | 22,500 | 0.00 USD | $0 | SEC |
| Mar 3, 2026 | AwardD | 43,536 | 0.00 USD | $0 | SEC |
| Mar 3, 2026 | AwardD | 18,100 | 0.00 USD | $0 | SEC |